INTERFACE ANALYSIS - History of Changes


DateDescription
2023-05-02 delete address 1821 Saratoga Ave, Suite #200 Saratoga, CA 95070
2023-05-02 delete address 4950 Hamilton Ave, Suite #104 San Jose, CA 95130
2023-05-02 insert address 1821 Saratoga Ave, Suite #280 Saratoga, CA 95070
2023-05-02 insert phone (408) 834-8443
2023-05-02 update primary_contact 1821 Saratoga Ave, Suite #200 Saratoga, CA 95070 => 1821 Saratoga Ave, Suite #280 Saratoga, CA 95070
2021-04-18 update website_status FlippedRobots => Disallowed
2021-02-26 update website_status OK => FlippedRobots
2021-01-25 update website_status Disallowed => OK
2021-01-25 delete address 1821 Saratoga Avenue, Suite #200 Saratoga, CA 95070
2021-01-25 delete email us..@interface-analysis.com
2021-01-25 insert email an..@interface-analysis.com
2020-03-30 update website_status FlippedRobots => Disallowed
2020-03-10 update website_status OK => FlippedRobots
2017-09-27 insert address 1821 Saratoga Ave, Suite #200 Saratoga, CA 95070
2016-01-11 update website_status FlippedRobots => OK
2015-11-26 update website_status OK => FlippedRobots
2013-07-06 insert address 1821 Saratoga Avenue, Suite #200 Saratoga, CA 95070
2013-07-06 insert address 4950 Hamilton Ave, Suite 104 San Jose, CA 95130
2013-07-06 insert client Titan Pharmaceuticals
2013-07-06 insert client Xeris Pharmaceuticals
2013-05-08 insert client_pages_linkeddomain technewsdaily.com
2013-05-08 insert contact_pages_linkeddomain technewsdaily.com
2013-05-08 insert index_pages_linkeddomain technewsdaily.com
2013-05-08 insert portfolio_pages_linkeddomain technewsdaily.com
2013-05-08 insert product_pages_linkeddomain technewsdaily.com
2013-05-08 insert terms_pages_linkeddomain technewsdaily.com
2013-04-13 delete address 1821 Saratoga Ave Saratoga, CA 95070
2013-04-13 insert client Baxter
2013-04-13 insert client Biomarin
2013-04-13 insert client Douglas Pharmaceuticals
2013-04-13 insert client Revance Therapeutics
2013-04-13 insert client St. Renatus
2013-04-13 insert client Teva Pharmaceuticals
2013-04-13 insert client Valeant Pharmaceuticals
2013-04-13 insert person Dr. Kellie Taylor